- Home
- STRO vs STHO Comparison
STRO vs STHO Comparison
Compare STRO & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- STHO
- Stock Information
- Founded
- STRO 2003
- STHO N/A
- Country
- STRO United States
- STHO United States
- Employees
- STRO N/A
- STHO N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- STHO Real Estate
- Sector
- STRO Health Care
- STHO Real Estate
- Exchange
- STRO Nasdaq
- STHO Nasdaq
- Market Cap
- STRO 77.7M
- STHO 89.7M
- IPO Year
- STRO 2018
- STHO N/A
- Fundamental
- Price
- STRO $0.90
- STHO $6.49
- Analyst Decision
- STRO Hold
- STHO
- Analyst Count
- STRO 7
- STHO 0
- Target Price
- STRO $5.47
- STHO N/A
- AVG Volume (30 Days)
- STRO 1.2M
- STHO 106.4K
- Earning Date
- STRO 05-08-2025
- STHO 05-12-2025
- Dividend Yield
- STRO N/A
- STHO N/A
- EPS Growth
- STRO N/A
- STHO N/A
- EPS
- STRO N/A
- STHO N/A
- Revenue
- STRO $66,434,000.00
- STHO $113,297,000.00
- Revenue This Year
- STRO N/A
- STHO N/A
- Revenue Next Year
- STRO N/A
- STHO N/A
- P/E Ratio
- STRO N/A
- STHO N/A
- Revenue Growth
- STRO N/A
- STHO N/A
- 52 Week Low
- STRO $0.52
- STHO $6.06
- 52 Week High
- STRO $5.17
- STHO $14.50
- Technical
- Relative Strength Index (RSI)
- STRO 50.82
- STHO 49.69
- Support Level
- STRO $0.86
- STHO $6.06
- Resistance Level
- STRO $0.99
- STHO $6.62
- Average True Range (ATR)
- STRO 0.09
- STHO 0.24
- MACD
- STRO 0.00
- STHO 0.04
- Stochastic Oscillator
- STRO 68.44
- STHO 60.42
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.